NORRIS PERNE & FRENCH LLP/MI - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORRIS PERNE & FRENCH LLP/MI ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$50,000
-51.0%
10,500
-65.6%
0.01%
-53.3%
Q4 2017$102,000
+56.9%
30,5000.0%0.02%
+50.0%
Q3 2017$65,000
-13.3%
30,5000.0%0.01%
-23.1%
Q2 2017$75,000
+7.1%
30,5000.0%0.01%0.0%
Q1 2017$70,000
+133.3%
30,5000.0%0.01%
+116.7%
Q4 2016$30,000
-11.8%
30,5000.0%0.01%
-14.3%
Q3 2016$34,000
-24.4%
30,5000.0%0.01%
-30.0%
Q2 2016$45,000
+2.3%
30,5000.0%0.01%
+11.1%
Q1 2016$44,000
-12.0%
30,5000.0%0.01%
-10.0%
Q4 2015$50,000
-29.6%
30,5000.0%0.01%
-41.2%
Q3 2015$71,000
-14.5%
30,5000.0%0.02%
+6.2%
Q2 2015$83,000
-18.6%
30,5000.0%0.02%
-15.8%
Q1 2015$102,000
-3.8%
30,5000.0%0.02%0.0%
Q4 2014$106,000
-4.5%
30,500
+38.6%
0.02%
-9.5%
Q3 2014$111,00022,0000.02%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders